Next Article in Journal
Special Issue “Precision Medicine in Neurodevelopmental Disorders: Personalized Characterization of Autism from Molecules to Behavior”
Previous Article in Journal
Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
Previous Article in Special Issue
(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 12
Issue 6
10.3390/jpm12060917
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer

by
Werner Schroth
1,* and
Matthias Schwab
1,2,3
1
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, University of Tuebingen, 70376 Tuebingen, German
2
Department of Clinical Pharmacology, University of Tübingen, 69120 Tuebingen, Germany
3
Department of Biochemistry and Pharmacy, University of Tübingen, 69120 Tuebingen, Germany
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2022, 12(6), 917; https://doi.org/10.3390/jpm12060917
Submission received: 11 May 2022 / Accepted: 13 May 2022 / Published: 1 June 2022
(This article belongs to the Special Issue Genome Research and Personalized Medicine in Breast Cancer)
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The Special Issue “Genome Research and Personalized Medicine in Breast Cancer” presents studies on personalized medicine in breast cancer, originally with a focus on genomic treatment prediction at all stages of disease [...]

Share and Cite

MDPI and ACS Style

Schroth, W.; Schwab, M. Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer. J. Pers. Med. 2022, 12, 917. https://doi.org/10.3390/jpm12060917

AMA Style

Schroth W, Schwab M. Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer. Journal of Personalized Medicine. 2022; 12(6):917. https://doi.org/10.3390/jpm12060917

Chicago/Turabian Style

Schroth, Werner, and Matthias Schwab. 2022. "Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer" Journal of Personalized Medicine 12, no. 6: 917. https://doi.org/10.3390/jpm12060917

APA Style

Schroth, W., & Schwab, M. (2022). Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer. Journal of Personalized Medicine, 12(6), 917. https://doi.org/10.3390/jpm12060917

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop